SAFETY AND EFFICACY OF PROLONGED CYTOMEGALOVIRUS PROPHYLAXIS WITH INTRAVENOUS GANCICLOVIR IN PEDIATRIC AND YOUNG ADULT LUNG TRANSPLANT RECIPIENTS

BACKGROUND: Cytomegalovirus (CMV) infection causes morbidity and mortality after transplantation. Despite a wide range of prevention strategies among pediatric lung transplant programs, the optimal duration of prophylactic therapy against CMV infection in pediatric lung transplantation is unknown. O...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Spivey, John F., Jewell, Dana, Sweet, Stuart, Storch, Gregory A., Hayashi, Robert J., Huddleston, Charles B., Danziger-Isakov, Lara A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2007
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1930168/
https://ncbi.nlm.nih.gov/pubmed/17430489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1399-3046.2006.00626.x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky